Reported results
- ARCALYST net product revenue was $286.0 million for the third quarter of 2026.
- Total operating expenses for the third quarter of 2026 were $231.7 million.
- Net income for the third quarter of 2026 was $47.3 million.
- Total operating expenses for the third quarter of 2026 included $13.1 million in non-cash, share-based compensation expense.
- As of September 30, 2026, Kiniksa had $568.8 million of cash, cash equivalents, and short-term investments.
Guidance
- Kiniksa expects 2026 ARCALYST net product revenue of between $1.045 billion and $1.050 billion.
- Kiniksa expects 2026 R&D expenses of between $160 million and $170 million.
- Kiniksa expects 2026 SG&A expenses of between $270 million and $280 million.
- Kiniksa expects its current operating plan to remain cash flow positive on an annual basis.
Price and volatility reaction
The stock moved +22.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +59.5 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 72.98 | 2026-10-26 |
| Close after release | 89.2 | 2026-10-27 |
| Realised move | +22.2% | close to close |
| 30d ATM IV change | +59.5 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.
